Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma

被引:19
|
作者
Kido, Toshimi [1 ]
Kurata, Hideaki [2 ]
Kondo, Kazuo [3 ]
Itakura, Hiroshige [4 ]
Okazaki, Mitsuyo [5 ]
Urata, Takeyoshi [6 ,7 ,9 ]
Yokoyama, Shinji [8 ]
机构
[1] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan
[2] Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med,Minato Ku, Tokyo 1058461, Japan
[3] Toyo Univ, Dept Food & Nutr Sci, Itakura, Gunma 3740193, Japan
[4] Shinagawa East One Med Clin, Minato Ku, Tokyo 1080075, Japan
[5] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138519, Japan
[6] Int Mibyou Pre Symptomat Med Med Ctr, Ryugasaki, Ibaraki 3010033, Japan
[7] Showa Univ, Dept Pharmacogen, Shinagawa Ku, Tokyo 1428555, Japan
[8] Chubu Univ, Nutr Hlth Sci Res Ctr, Matsumoto Cho, Kasugai, Aichi 4878501, Japan
[9] Showa Univ, Dept Diabet Metab & Endocrinol, Sch Med, Shinagawa Ku, Tokyo 1428666, Japan
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
HIGH-DENSITY-LIPOPROTEIN; TRANSFER PROTEIN; APOA-I; DEFICIENCY; SUBCLASSES; ACCUMULATION; DISPLACEMENT; INHIBITION; MECHANISM;
D O I
10.1038/srep31532
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Plasma concentration of apoA-I, apoA-II and apoA-II-unassociated apoA-I was analyzed in 314 Japanese subjects (177 males and 137 females), including one (male) homozygote and 37 (20 males and 17 females) heterozygotes of genetic CETP deficiency. ApoA-I unassociated with apoA-II markedly and linearly increased with HDL-cholesterol, while apoA-II increased only very slightly and the ratio of apoAII- associated apoA-I to apoA-II stayed constant at 2 in molar ratio throughout the increase of HDL-cholesterol, among the wild type and heterozygous CETP deficiency. Thus, overall HDL concentration almost exclusively depends on HDL with apoA-I without apoA-II (LpAI) while concentration of HDL containing apoA-I and apoA-II (LpAI: AII) is constant having a fixed molar ratio of 2 : 1 regardless of total HDL and apoA-I concentration. Distribution of apoA-I between LpAI and LpAI: AII is consistent with a model of statistical partitioning regardless of sex and CETP genotype. The analysis also indicated that LpA-I accommodates on average 4 apoA-I molecules and has a clearance rate indistinguishable from LpAI: AII. Independent evidence indicated LpAI: A-II has a diameter 20% smaller than LpAI, consistent with a model having two apoA-I and one apoA-II. The functional contribution of these particles is to be investigated.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I:A-II levels
    Richard, F
    Marecaux, N
    Dallongeville, J
    Devienne, M
    Tiem, N
    Fruchart, JC
    Fantino, M
    Zylberberg, G
    Amouyel, P
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06): : 711 - 715
  • [32] Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity
    Alexander, Eric T.
    Phillips, Michael C.
    JOURNAL OF LIPID RESEARCH, 2013, 54 (12) : 3464 - 3470
  • [33] Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
    Melchior, John T.
    Street, Scott E.
    Vaisar, Tomas
    Hart, Rachel
    Jerome, Jay
    Kuklenyik, Zsuzsanna
    Clouet-Foraison, Noemie
    Thornock, Carissa
    Bedi, Shimpi
    Shah, Amy S.
    Segrest, Jere P.
    Heinecke, Jay W.
    Davidson, W. Sean
    JOURNAL OF LIPID RESEARCH, 2021, 62
  • [34] Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease -: The PRIME Study
    Luc, G
    Bard, JM
    Ferrières, J
    Evans, A
    Amouyel, P
    Arveiler, D
    Fruchart, JC
    Ducimetière, P
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) : 1155 - 1161
  • [35] APOLIPOPROTEIN A-I AND A-II LEVELS IN AN AUSTRALIAN POPULATION
    MA, X
    WEARNE, K
    LYNCH, WJ
    MASAREI, JRL
    PATHOLOGY, 1989, 21 (01) : 42 - 45
  • [36] Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-β HDL containing apolipoprotein A-II
    Pastier, D
    Dugué, S
    Boisfer, E
    Atger, V
    Tran, NQ
    van Tol, A
    Chapman, MJ
    Chambaz, J
    Laplaud, PM
    Kalopissis, AD
    BIOCHEMISTRY, 2001, 40 (41) : 12243 - 12253
  • [37] PLASMA APOLIPOPROTEIN CONCENTRATIONS IN FAMILIAL APOLIPOPROTEIN A-I AND A-II DEFICIENCY (TANGIER DISEASE)
    ALAUPOVIC, P
    SCHAEFER, EJ
    MCCONATHY, WJ
    FESMIRE, JD
    BREWER, HB
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (08): : 805 - 809
  • [38] Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis
    McComb, Mason
    Krikheli, Maggie
    Uher, Tomas
    Browne, Richard W.
    Srpova, Barbora
    Oechtering, Johanna
    Maceski, Aleksandra Maleska
    Tyblova, Michaela
    Jakimovski, Dejan
    Ramasamy, Deepa P.
    Bergsland, Niels
    Krasensky, Jan
    Noskova, Libuse
    Fialova, Lenka
    Weinstock-Guttman, Bianca
    Havrdova, Eva Kubala
    Vaneckova, Manuela
    Zivadinov, Robert
    Horakova, Dana
    Kuhle, Jens
    Ramanathan, Murali
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (05) : 675 - +
  • [39] DECREASE OF PLASMA APO A-I IN CORONARY-ARTERY DISEASE IS RELATED TO LIPOPROTEIN PARTICLES WHICH CONTAIN APO A-I BUT NOT APO A-II
    PUCHOIS, P
    BERTRAND, M
    LABLANCHE, JM
    FRUCHART, JC
    CIRCULATION, 1985, 72 (04) : 199 - 199
  • [40] CAPILLARY GEL-ELECTROPHORESIS ANALYSIS OF APOLIPOPROTEINS A-I AND A-II IN HUMAN HIGH-DENSITY-LIPOPROTEINS
    GOUX, A
    ATHIAS, A
    PERSEGOL, L
    LAGROST, L
    GAMBERT, P
    LALLEMANT, C
    ANALYTICAL BIOCHEMISTRY, 1994, 218 (02) : 320 - 324